Ensuring adherence to therapy with anticoagulation in patients with atrial fibrillation

Jeroen M. Hendriks, Celine Gallagher, Prashanthan Sanders

Research output: Contribution to journalEditorial

9 Citations (Scopus)


Atrial fibrillation (AF) is a significant burden for healthcare systems due to increased morbidity and mortality rates. It is a major cause of ischaemic stroke, which is considered one of the most serious and disabling complications of AF. Stroke prevention with oral anticoagulation (OAC) by vitamin K antagonists (VKA) or non-vitamin K antagonists (NOAC) is therefore a significant component of AF management. Both VKAs and NOACs are effective for the prevention of stroke in AF; however, stringent adherence to the recommended treatment regimen is crucial, both from a prescriber’s and a patient’s perspective.
Original languageEnglish
Pages (from-to)1308-1309
Number of pages2
Issue number17
Publication statusPublished - Sept 2017
Externally publishedYes


  • Atrial fibrillation
  • Health care delivery
  • Medication adherence
  • Stroke


Dive into the research topics of 'Ensuring adherence to therapy with anticoagulation in patients with atrial fibrillation'. Together they form a unique fingerprint.

Cite this